Regulation of cellular processes by PPAR? ligands in neuroblastoma cells is modulated by the level of retinoblastoma protein expression
Emmans, V.C., Rodway, H.A., Hunt, A.N. and Lillycrop, K.A. (2004) Regulation of cellular processes by PPAR? ligands in neuroblastoma cells is modulated by the level of retinoblastoma protein expression. Biochemical Society Transactions, 32, 840-842.
Full text not available from this repository.
Neuroblastoma is a childhood cancer, which spontaneously regresses. This has led to a search for agents that mimic this process. We show that both natural and synthetic ligands of PPAR? (peroxisome-proliferator-activated receptor ?) inhibit the growth of neuroblastoma cells in vitro. The degree of PPAR activation was attenuated however in the presence of the retinoblastoma protein. Addition of trichostatin A, a histone deacetylase inhibitor, abolished retinoblastoma protein repression of PPAR activity. Moreover, enhanced growth inhibition was observed when neuroblastoma cells were treated with a PPAR? ligand and a histone deacetylase inhibitor, suggesting a combination therapy to treat neuroblastoma might prove more effective than using either agent alone.
|Keywords:||cancer, neuroblastoma cells, nuclear receptor, peroxisome-proliferator-activated receptor ? (ppar?), retinoblastoma protein, transcription|
|Subjects:||R Medicine > RC Internal medicine > RC0321 Neuroscience. Biological psychiatry. Neuropsychiatry
R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer)
R Medicine > RJ Pediatrics
|Divisions :||University Structure - Pre August 2011 > School of Biological Sciences
University Structure - Pre August 2011 > School of Medicine > Infection, Inflammation and Repair
|Accepted Date and Publication Date:||
|Date Deposited:||26 Apr 2006|
|Last Modified:||31 Mar 2016 11:50|
|RDF:||RDF+N-Triples, RDF+N3, RDF+XML, Browse.|
Actions (login required)